This pivotal study is designed to test the accuracy of the gene signatures from CS2b generated on prostate tissue in urine, allowing for the development of a highly accurate prostate cancer screening test that utilises the non-invasive sample source of urine. In total, Caldera will recruit a minimum of 300 donors who will donate matched […]
Caldera Health will hold its Annual General meeting at the end of November to update shareholders of the considerable progress made in the last 12 months including the successful completion of Clinical Study 2b confirming world class accuracy in tissue samples, and the start of Clinical Study 3.
Caldera will be participating in the TIKI (Technology Innovation and Knowledge Interchange) Tour hosted by the Ministry of Health in Wellington at the end of November in partnership with CMDT and MedTech CoRE. This is an innovation showcase to highlight the latest in healthcare technologies & research, and facilitate discussions with companies and researchers. The […]